Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Tirzepatide (Dual Agonist) Molecule: Tirzepatide Brands: Mounjaro (Eli Lilly) Yurpeak (Cipla, India) Tirzepatide works on two pathways: GLP-1 GIP (Glucose-dependent insulinotropic polypeptide) This dual mechanism allows: Better appetite control Improved insulin response Greater weight loss outcomes Why Calling Everything Ozempic Is Misleading When we use Ozempic to describe all GLP-1 medications, we: Oversimplify a complex category Ignore meaningful differences between drugs Create unrealistic expectations Most importantly: Not all medications deliver the same results
Wegovys maintenance dose (2.4mg weekly) is higher than standard Ozempic doses, leading to greater appetite suppression and typically more rapid weight loss
Resources We Trust Mayo Clinic: Alcohol Use Disorder: Diagnosis & Treatment Cleveland Clinic: GLP-1 Agonists National Institute on Alcohol Abuse and Alcoholism: Understanding Alcohol Use Disorder American Psychiatric Association: Alcohol Use Disorder MedlinePlus: Alcohol Use Disorder (AUD) Brunchmann A et al
Do GLP-1 Patches Actually Work
16.1% on placebo) Diarrhea: 29.7% (vs
US$ 26.73
US$ 26.50
US$ 24.00
US$ 28.96
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
%20(1).png)
US$ 21.30
